rhodium has been researched along with Prostatic Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, X; Dong, S; Li, P; Luo, Z; Peng, B; Su, W; Xiao, JA | 1 |
| Leung, CH; Li, G; Liang, JX; Ma, DL; Vellaisamy, K; Wang, W; Wong, CY; Yang, C | 1 |
2 other study(ies) available for rhodium and Prostatic Neoplasms
| Article | Year |
|---|---|
Novel half-sandwich rhodium(III) and iridium(III) photosensitizers for dual chemo- and photodynamic therapy.
Topics: Adenocarcinoma; Antineoplastic Agents; Cell Line, Tumor; Female; Humans; In Vitro Techniques; Iridium; Male; Ovarian Neoplasms; Photochemotherapy; Photosensitizing Agents; Prostatic Neoplasms; Rhodium | 2019 |
A Rhodium(III)-Based Inhibitor of Lysine-Specific Histone Demethylase 1 as an Epigenetic Modulator in Prostate Cancer Cells.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Coordination Complexes; Epigenesis, Genetic; Gene Expression Regulation, Neoplastic; Histone Demethylases; Humans; Male; Molecular Docking Simulation; Prostate; Prostatic Neoplasms; Rhodium | 2017 |